BARTELS EPSTEIN-BARR VIRUS IGM EIA— 510(k) K922331

Name: FDA 510(k) clearance K922331
Creator: U.S. Food and Drug Administration
Published: 1992-09-02

Substantially Equivalent

Baxter Diagnostics, Inc.

FDA 510(k) clearance K922331 for BARTELS EPSTEIN-BARR VIRUS IGM EIA, Substantially Equivalent on 1992-09-02. Applicant: Baxter Diagnostics, Inc.. Device class: 1.

Clearance details

Applicant: Baxter Diagnostics, Inc.
Product code: Code LJN
Device class: Class 1
Regulation: 21 CFR 866.3235
Advisory panel: Microbiology
Date received: 1992-05-13
Decision date: 1992-09-02
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Bellevue, WA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LJN

view all

K123021 — BIOPLEX 2200 EBV IGM KIT2012-11-02
K073381 — PLEXUS EBV IGM MULTI-ANALYTE DIAGNOSTICS, MODEL: MP0600M2008-08-04
K042092 — ATHENA MULTI-LYTE EBV VCA IGM TEST SYSTEM2005-04-12
K033780 — MODIFICATION TO SERAQUEST VCA IGM2004-01-15
K990977 — SERAQUEST EB VAC IGM1999-10-06

More clearances from Baxter Diagnostics, Inc.

view all

K934458 — DRIED GRAM-POSITIVE MIC/COMBO PANELS1995-07-18
K950817 — DRIED GRAM POSITIVE MIC/COMBO PANELS/PNEUMOCOCCI1995-04-25
K935704 — DRIED GRAM-NEGATIVE MIC//COMBO PANELS1995-04-14
K950570 — STRATUS PROGESTERONE FLUOROMETRIC ENZYME IMMUNOASSAY1995-04-11
K945235 — DRIED GRAM-POSITIVE MIC/COMBO PANELS1995-03-07

Data sourced from openFDA. This site is unofficial and independent of the FDA.